BridgeBio Oncology Therapeutics Inc.
General ticker "BBOT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $272.5M (TTM average)
BridgeBio Oncology Therapeutics Inc. follows the US Stock Market performance with the rate: 23.4%.
Estimated limits based on current volatility of 5.8%: low 12.44$, high 13.97$
Factors to consider:
- Total employees count: 3 as of 2024
Short-term BBOT quotes
Long-term BBOT plot
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $80.86MM |
| Operating Income | $-80.86MM |
| Non-Operating Income | $6.59MM |
| R&D Expense | $73.11MM |
| Income(Loss) | $-74.28MM |
| Profit(Loss)* | $7.60MM |
| Stockholders Equity | $188.72MM |
| Assets | $194.42MM |
| Operating Cash Flow | $-0.76MM |
| Investing Cash Flow | $-184.00MM |
| Financing Cash Flow | $186.46MM |
| Earnings Per Share** | $0.46 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.